Royalty Pharma plc
RPRX
주식 순위
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
주가
$62.20
마지막 동기화: 2026-10-21
시가총액
$27.69B
변동 (1일)
-0.09%
변동 (1년)
68.82%
국가
US
거래 Royalty Pharma plc (RPRX)
카테고리
Healthcare
Royalty Pharma plc (RPRX)의 주가 이력
최고 종가: $58.43 (2026-10-01 기준)
최저 종가: $49.50 (2020-06-01 기준)
최저 종가: $49.50 (2020-06-01 기준)
Royalty Pharma plc의 주가 이력 (2020 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $45.29 | 34.87% |
SE
|
|
| $170.92 | 23.58% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
|
| $0.63 | -31.50% |
HK
|
